

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>The evolution of medulloblastoma therapy to... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-490/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-490" />
    
            <meta name="description" content="Read the original article in full on F1000Research: The evolution of medulloblastoma therapy to personalized medicine" />
    
            <meta name="og:title" content="F1000Research Article: The evolution of medulloblastoma therapy to personalized medicine.">
            <meta name="og:description" content="Read the latest article version by Soma Sengupta, Daniel Pomeranz Krummel, Scott Pomeroy, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="11709">
            <meta name="article-id" content="10859">
            <meta name="dc.title" content="The evolution of medulloblastoma therapy to personalized medicine">
            <meta name="dc.description" content="Recent advances in cancer genomics have revolutionized the characterization and classification of medulloblastomas. According to the current WHO guidelines, medulloblastomas are now classified into the following molecularly defined groups: Wnt signaling pathway (WNT)-activated, sonic hedgehog signaling pathway (SHH)-activated and tumor suppressor protein p53 (TP53)-mutant, SHH-activated and TP53-wildtype, and non-WNT/non-SHH (i.e. group 3 and group 4). Importantly, genomic, epigenomic, and proteomic advances have created a potential paradigm shift in therapeutic options. The challenge now is to (i) translate these observations into new therapeutic approaches and (ii) employ these observations in clinical practice, utilizing the classification following a molecular analysis for diagnosis and application of new subgroup-specific targeted therapeutics.">
            <meta name="dc.subject" content="Medulloblastoma, specific targeted therapeutics, WNT, SHH, TP53">
            <meta name="dc.creator" content="Sengupta, Soma">
            <meta name="dc.creator" content="Pomeranz Krummel, Daniel">
            <meta name="dc.creator" content="Pomeroy, Scott">
            <meta name="dc.date" content="2017/04/13">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.10859.1">
            <meta name="dc.source" content="F1000Research 2017 6:490">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="Medulloblastoma">
            <meta name="prism.keyword" content="specific targeted therapeutics">
            <meta name="prism.keyword" content="WNT">
            <meta name="prism.keyword" content="SHH">
            <meta name="prism.keyword" content="TP53">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/04/13">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="490">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.10859.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-490">
            <meta name="citation_title" content="The evolution of medulloblastoma therapy to personalized medicine">
            <meta name="citation_abstract" content="Recent advances in cancer genomics have revolutionized the characterization and classification of medulloblastomas. According to the current WHO guidelines, medulloblastomas are now classified into the following molecularly defined groups: Wnt signaling pathway (WNT)-activated, sonic hedgehog signaling pathway (SHH)-activated and tumor suppressor protein p53 (TP53)-mutant, SHH-activated and TP53-wildtype, and non-WNT/non-SHH (i.e. group 3 and group 4). Importantly, genomic, epigenomic, and proteomic advances have created a potential paradigm shift in therapeutic options. The challenge now is to (i) translate these observations into new therapeutic approaches and (ii) employ these observations in clinical practice, utilizing the classification following a molecular analysis for diagnosis and application of new subgroup-specific targeted therapeutics.">
            <meta name="citation_description" content="Recent advances in cancer genomics have revolutionized the characterization and classification of medulloblastomas. According to the current WHO guidelines, medulloblastomas are now classified into the following molecularly defined groups: Wnt signaling pathway (WNT)-activated, sonic hedgehog signaling pathway (SHH)-activated and tumor suppressor protein p53 (TP53)-mutant, SHH-activated and TP53-wildtype, and non-WNT/non-SHH (i.e. group 3 and group 4). Importantly, genomic, epigenomic, and proteomic advances have created a potential paradigm shift in therapeutic options. The challenge now is to (i) translate these observations into new therapeutic approaches and (ii) employ these observations in clinical practice, utilizing the classification following a molecular analysis for diagnosis and application of new subgroup-specific targeted therapeutics.">
            <meta name="citation_keywords" content="Medulloblastoma, specific targeted therapeutics, WNT, SHH, TP53">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Soma Sengupta">
            <meta name="citation_author_institution" content="Winship Cancer Institute, Emory University Hospital, Atlanta, GA, USA">
            <meta name="citation_author" content="Daniel Pomeranz Krummel">
            <meta name="citation_author_institution" content="Winship Cancer Institute, Emory University Hospital, Atlanta, GA, USA">
            <meta name="citation_author" content="Scott Pomeroy">
            <meta name="citation_author_institution" content="F.M. Kirby Neurobiology Center, Boston Children&rsquo;s Hospital, Boston, MA, USA">
            <meta name="citation_publication_date" content="2017/04/13">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="490">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.10859.1">
            <meta name="citation_firstpage" content="490">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-490/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-490.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=11709 /> <input type=hidden id=articleId name=articleId value=10859 /> <input type=hidden id=xmlUrl value="/articles/6-490/v1/xml"/> <input type=hidden id=xmlFileName value="-6-490-v1.xml"> <input type=hidden id=article_uuid value=86e1cc06-42f1-4e9d-bafd-1e9a2958d65d /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="The evolution of medulloblastoma therapy to personalized medicine"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.10859.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.10859.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-490"
  },
  "headline": "The evolution of medulloblastoma therapy to personalized medicine",
  "datePublished": "2017-04-13T13:53:58",
  "dateModified": "2017-04-13T13:53:58",
  "author": [
    {
      "@type": "Person",
      "name": "Soma Sengupta"
    },    {
      "@type": "Person",
      "name": "Daniel Pomeranz Krummel"
    },    {
      "@type": "Person",
      "name": "Scott Pomeroy"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Recent advances in cancer genomics have revolutionized the characterization and classification of medulloblastomas. According to the current WHO guidelines, medulloblastomas are now classified into the following molecularly defined groups: Wnt signaling pathway (WNT)-activated, sonic hedgehog signaling pathway (SHH)-activated and tumor suppressor protein p53 (TP53)-mutant, SHH-activated and TP53-wildtype, and non-WNT/non-SHH (i.e. group 3 and group 4). Importantly, genomic, epigenomic, and proteomic advances have created a potential paradigm shift in therapeutic options. The challenge now is to (i) translate these observations into new therapeutic approaches and (ii) employ these observations in clinical practice, utilizing the classification following a molecular analysis for diagnosis and application of new subgroup-specific targeted therapeutics."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-490",
            "name": "The evolution of medulloblastoma therapy to personalized medicine"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> The evolution of medulloblastoma therapy to personalized medicine </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=11709 data-id=10859 data-downloads="" data-views="" data-scholar="10.12688/f1000research.10859.1" data-recommended="" data-doi="10.12688/f1000research.10859.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-490/v1/pdf?article_uuid=86e1cc06-42f1-4e9d-bafd-1e9a2958d65d" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-10859-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-10859-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-10859-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Sengupta S, Pomeranz Krummel D and Pomeroy S. The evolution of medulloblastoma therapy to personalized medicine [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):490 (<a class=new-orange href="https://doi.org/10.12688/f1000research.10859.1" target=_blank>https://doi.org/10.12688/f1000research.10859.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-10859-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=10859 id=track-article-signin-10859 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/10859?target=/articles/6-490">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=11709 /> <input name=articleId type=hidden value=10859 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>The evolution of medulloblastoma therapy to personalized medicine</h1><span class=other-info> [version 1; peer review: 3 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Soma Sengupta<a href="https://orcid.org/0000-0003-4577-1397" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-4577-1397</div><sup>1</sup>,&nbsp;</span><span class="">Daniel Pomeranz Krummel<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:scott.pomeroy@childrens.harvard.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Scott Pomeroy</span></a><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Soma Sengupta<a href="http://orcid.org/0000-0003-4577-1397" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-4577-1397</div><sup>1</sup>,&nbsp;</span><span class="">Daniel Pomeranz Krummel<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:scott.pomeroy@childrens.harvard.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Scott Pomeroy</span></a><sup>2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 13 Apr 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.10859.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Winship Cancer Institute, Emory University Hospital, Atlanta, GA, USA<br/> <sup>2</sup> F.M. Kirby Neurobiology Center, Boston Children&rsquo;s Hospital, Boston, MA, USA<br/> <p> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=21824-21580></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=21825-21578></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=21823-21579></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Recent advances in cancer genomics have revolutionized the characterization and classification of medulloblastomas. According to the current WHO guidelines, medulloblastomas are now classified into the following molecularly defined groups: Wnt signaling pathway (WNT)-activated, sonic hedgehog signaling pathway (SHH)-activated and tumor suppressor protein p53 (TP53)-mutant, SHH-activated and TP53-wildtype, and non-WNT/non-SHH (i.e. group 3 and group 4). Importantly, genomic, epigenomic, and proteomic advances have created a potential paradigm shift in therapeutic options. The challenge now is to (i) translate these observations into new therapeutic approaches and (ii) employ these observations in clinical practice, utilizing the classification following a molecular analysis for diagnosis and application of new subgroup-specific targeted therapeutics. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> Medulloblastoma, specific targeted therapeutics, WNT, SHH, TP53 </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Scott Pomeroy (<a href="mailto:scott.pomeroy@childrens.harvard.edu">scott.pomeroy@childrens.harvard.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Scott Pomeroy </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> The authors declare that they have no competing interests. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> Soma Sengupta is supported by the National Institute of Neurological Disorders and Stroke grant (K08 NS083626), and the Winship Cancer Institute Institutional Research grant (IRG-14-188-01) from the American Cancer Society. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 Sengupta S <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the <a href="http://creativecommons.org/publicdomain/zero/1.0/" target=_blank data-test-id=box-data-licence-link>Creative Commons Zero "No rights reserved" data waiver</a> (CC0 1.0 Public domain dedication). </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Sengupta S, Pomeranz Krummel D and Pomeroy S. The evolution of medulloblastoma therapy to personalized medicine [version 1; peer review: 3 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):490 (<a href="https://doi.org/10.12688/f1000research.10859.1" target=_blank>https://doi.org/10.12688/f1000research.10859.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 13 Apr 2017, <b>6</b>(F1000 Faculty Rev):490 (<a href="https://doi.org/10.12688/f1000research.10859.1" target=_blank>https://doi.org/10.12688/f1000research.10859.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 13 Apr 2017, <b>6</b>(F1000 Faculty Rev):490 (<a href="https://doi.org/10.12688/f1000research.10859.1" target=_blank>https://doi.org/10.12688/f1000research.10859.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d10921e200>Introduction</h2><p class="" id=d10921e203>Medulloblastomas account for 12% of childhood brain tumors<sup><a href="#ref-1">1</a></sup>. Approximately 80% of medulloblastomas occur in children under the age of 15. In adults, medulloblastomas are rare (1–2%). To date, the 5-year survival rate for children with average and high-risk disease as defined by clinical criteria is 80% and 60–65%, respectively<sup><a href="#ref-2">2</a></sup>. Recent advances in cancer genomics have led to a fundamental change in medulloblastoma classification. Based on genome-wide transcription profiling, it has been shown that medulloblastomas comprise at least four molecular subgroups (<a href="#T1">Table 1</a>), each with unique transcription profiles, mechanism of tumorigenesis, and clinical outcome<sup><a href="#ref-3">3</a>–<a href="#ref-6">6</a></sup>. Each of these subgroups, Wnt signaling pathway (WNT) (10% of medulloblastomas), sonic hedgehog signaling pathway (SHH) (30%), group 3 (15%), and group 4 (45%), will be discussed in the following sections.</p><div class="table-wrap panel clearfix"><a name=T1 class=n-a></a><div class=caption><h3>Table 1. Features of medulloblastoma subgroups.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d10921e235 class=n-a></a><thead><a name=d10921e237 class=n-a></a><tr><a name=d10921e239 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d10921e241 class=n-a></a>Subtype</th><th align=left colspan=1 rowspan=1 valign=top><a name=d10921e244 class=n-a></a>Molecular characteristics</th><th align=left colspan=1 rowspan=1 valign=top><a name=d10921e247 class=n-a></a>Mutations</th><th align=left colspan=1 rowspan=1 valign=top><a name=d10921e250 class=n-a></a>Age group</th></tr></thead><tbody><a name=d10921e255 class=n-a></a><tr><a name=d10921e257 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e259 class=n-a></a> <b>WNT activated</b> </td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e265 class=n-a></a>WNT pathway activation</td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e268 class=n-a></a>CTNNB1<br class=br>DDX3X<br class=br>Chromatin-remodeling<br class=br>genes<br class=br>TP53</td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e279 class=n-a></a>Least common of subgroups<br class=br>Found in children and adults, not<br class=br>infants</td></tr><tr><a name=d10921e287 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e289 class=n-a></a> <b>SHH activated and TP53 wild-</b><br class=br><b>type</b> </td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e298 class=n-a></a>SHH pathway activation</td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e301 class=n-a></a>PTCH1<br class=br>SMO<br class=br>SUFU<br class=br>TERT promoter<br class=br>Chromatin-remodeling<br class=br>genes</td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e314 class=n-a></a>Infants, children, and adults</td></tr><tr><a name=d10921e318 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e320 class=n-a></a> <b>SHH activated and TP53</b><br class=br><b>mutant</b> </td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e329 class=n-a></a>SHH pathway activation</td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e332 class=n-a></a>TP53</td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e335 class=n-a></a>5–18 years old</td></tr><tr><a name=d10921e339 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e341 class=n-a></a> <b>Group 3</b> </td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e347 class=n-a></a>Elevated expression of MYC<br class=br>GABRA5 over-expression</td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e352 class=n-a></a>SMARCA4<br class=br>Chromatin-remodeling<br class=br>genes<br class=br>Genes of TGF-β pathway</td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e361 class=n-a></a>Infants and children, not adults<br class=br>More common in boys than in girls</td></tr><tr><a name=d10921e367 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e369 class=n-a></a> <b>Group 4</b> </td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e375 class=n-a></a>Lmx1A expression</td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e378 class=n-a></a>Chromatin-remodeling<br class=br>genes</td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e383 class=n-a></a>More common in children than in<br class=br>adults<br class=br>Least common in infants</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d10921e395 class=n-a></a><p id=d10921e397> CTNNB1, catenin beta 1; DDX3X, DEAD-box helicase 3; Lmx1a, LIM homeobox transcription factor; PTCH1, Patched-1; SHH, sonic hedgehog; SMARCA4, SWI (switching)/SNF (sucrose non-fermenting)-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A, member 4; SMO, smoothened receptor; SUFU, suppressor of fused homolog protein; TERT, telomerase reverse transcriptase; TGF-β, transforming growth factor beta; TP53, tumor suppressor protein p53.</p></div></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10921e406>Clinical behavior</h2><p class="" id=d10921e409>Medulloblastomas typically occur in the cerebellum and are primarily a pediatric brain cancer. Historically, medulloblastomas were described as “small round blue cell tumors”<sup><a href="#ref-7">7</a></sup>. The tumors are highly cellular with minimal cellular differentiation and have been defined by histological features that do not accurately predict clinical outcome (classic, desmoplastic/nodular, large-cell/anaplastic, medulloblastoma with neuroblastic features, medulloblastoma with glial differentiation, medullomyoblastoma, and melanotic medulloblastoma). Approximately one-third of the tumors have metastatic spread through CSF pathways, which puts the tumor into a “high-risk” group and is associated with poor outcome. In terms of MRI imaging characteristics, an adult medulloblastoma patient exhibits disseminated leptomeningeal disease in the brain and spinal cord (<a href="#f1">Figure 1A</a>), while pediatric medulloblastoma patients of the WNT subgroup tend to be in the cerebellar peduncle, patients of the SHH subgroup tend to be in the cerebellar hemisphere, but can be centrally located, as shown in <a href="#f1">Figure 1B</a>, and midline cerebellar tumors tend to belong to groups 3 and 4 or SHH<sup><a href="#ref-8">8</a></sup>.</p><div class="fig panel clearfix"><a name=f1 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/11709/c9e8b92d-323a-4a64-b662-3ddae7434989_figure1.gif"><img alt="c9e8b92d-323a-4a64-b662-3ddae7434989_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/11709/c9e8b92d-323a-4a64-b662-3ddae7434989_figure1.gif"></a><div class=caption><h3>Figure 1. Imaging of pediatric and adult medulloblastomas.</h3><p id=d10921e436>(<b>A</b>) Magnetic resonance imaging of an adult woman who has medulloblastoma in the brain and spine with leptomeningeal spread: (<b>a</b>) axial T1 of the brain post-gadolinium contrast; (<b>b</b>) coronal T1 of the brain post-gadolinium contrast; (<b>c</b>) sagittal T1 of the cervical spine post-gadolinium contrast. (<b>B</b>) Brain magnetic resonance imaging of pediatric medulloblastomas: (<b>a</b>) sagittal post-gadolinium WNT tumor; (<b>b</b>) axial T2 of a SHH tumor. Red arrows delineate the tumor/leptomeningeal disease.</p></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10921e468>Treatment: current standard of care</h2><p class="" id=d10921e471>Medulloblastomas are clinically categorized as average-risk and high-risk disease<sup><a href="#ref-9">9</a></sup> (<a href="#T2">Table 2</a>). Maximal surgical resection, in tumors that are amenable to surgery, is the first step in all cases. However, cerebellar mutism (severely diminished or absent speech output) can be an acute post-surgical complication in up to one-quarter of patients, which usually partially recovers, although survivors typically are left with dysarthria and neurocognitive issues<sup><a href="#ref-10">10</a></sup>. For average-risk disease, patients receive craniospinal radiotherapy (23.4 Gy in 30 fractions, followed by conformal tumor bed boost to 54–56 Gy over 6 weeks) with or without vincristine. After the radiation, children older than 3 years with non-disseminated medulloblastoma receive eight cycles of vincristine (mitotic inhibitor), cisplatin (DNA cross-linker), and two alkylating agents – cyclophosphamide and CCNU (lomustine) chemotherapy – for approximately 1 year. For poor-risk disease, craniospinal radiotherapy is given at a higher dose (36–39.6 Gy in 30 fractions, followed by posterior fossa boost to 54–56 Gy over 6 weeks) and chemotherapy (agents used include cisplatin, cyclophosphamide, and vincristine)<sup><a href="#ref-9">9</a>,<a href="#ref-11">11</a></sup>. Sometimes, stem cell transplants are also offered prior to the initiation of therapy. The craniospinal radiation and chemotherapy regimens described are also for the most part used in adult patients, but the use of post-adjuvant chemotherapy has not been shown to improve survival. In addition, vincristine and cisplatin cause significant toxicity. Infants younger than 3 years are often treated with high-dose chemotherapy and stem cell rescue regimens to delay the time to or avoid completely the administration of craniospinal irradiation<sup><a href="#ref-9">9</a>,<a href="#ref-11">11</a></sup>.</p><p class="" id=d10921e499>Unfortunately, these treatment regimens come with considerable morbidity. For example, the majority of children treated with intensive chemotherapy and irradiation (especially infants and those exposed to higher doses) are at risk for significant hearing loss, endocrine and neurocognitive deficits, and secondary benign and malignant tumors<sup><a href="#ref-11">11</a></sup>.</p><div class="table-wrap panel clearfix"><a name=T2 class=n-a></a><div class=caption><h3>Table 2. Staging and risk stratification of medulloblastomas.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d10921e517 class=n-a></a><thead><a name=d10921e519 class=n-a></a><tr><a name=d10921e521 class=n-a></a><th align=left colspan=4 rowspan=1 valign=top><a name=d10921e523 class=n-a></a>Modified Chang Staging</th></tr><tr><a name=d10921e527 class=n-a></a><th align=left colspan=2 rowspan=1 valign=top><a name=d10921e529 class=n-a></a>T stage</th><th align=left colspan=2 rowspan=1 valign=top><a name=d10921e532 class=n-a></a>M stage</th></tr></thead><tbody><a name=d10921e537 class=n-a></a><tr><a name=d10921e539 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e541 class=n-a></a>T1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e544 class=n-a></a>Tumor &lt;3 cm in diameter</td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e547 class=n-a></a>M0</td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e550 class=n-a></a>No evidence of gross subarachnoid or<br class=br>hematogenous metastasis</td></tr><tr><a name=d10921e556 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e558 class=n-a></a>T2</td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e561 class=n-a></a>Tumor ≥3 cm in diameter</td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e564 class=n-a></a>M1</td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e567 class=n-a></a>Microscopic tumor cells found in CSF</td></tr><tr><a name=d10921e571 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e573 class=n-a></a>T3a</td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e576 class=n-a></a>Tumor &gt;3 cm and with extension<br class=br>into aqueduct of Sylvius or<br class=br>foramen of Luschka</td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e583 class=n-a></a>M2</td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e586 class=n-a></a>Gross nodular seeding intracranially beyond the<br class=br>primary site (in cerebellar/cerebral subarachnoid<br class=br>space or in third or lateral ventricle)</td></tr><tr><a name=d10921e594 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e596 class=n-a></a>T3b</td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e599 class=n-a></a>Tumor &gt;3 cm and with<br class=br>unequivocal extension into<br class=br>brainstem</td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e606 class=n-a></a>M3</td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e609 class=n-a></a>Gross nodular seeding in spinal subarachnoid<br class=br>space</td></tr><tr><a name=d10921e615 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e617 class=n-a></a>T4</td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e620 class=n-a></a>Tumor &gt;3 cm with extension past<br class=br>aqueduct of Sylvius or down<br class=br>past foramen magnum</td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e627 class=n-a></a>M4</td><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e630 class=n-a></a>Metastasis outside cerebrospinal axis</td></tr><tr><a name=d10921e635 class=n-a></a><th align=left colspan=4 rowspan=1 valign=top><a name=d10921e637 class=n-a></a>Risk Stratification</th></tr><tr><a name=d10921e641 class=n-a></a><th align=left colspan=2 rowspan=1 valign=top><a name=d10921e643 class=n-a></a>Standard (Average) Risk (66%)</th><th align=left colspan=2 rowspan=1 valign=top><a name=d10921e646 class=n-a></a>High Risk (34%)</th></tr><tr><a name=d10921e650 class=n-a></a><td align=left colspan=2 rowspan=1 valign=top><a name=d10921e652 class=n-a></a>&gt;3 years old</td><td align=left colspan=2 rowspan=1 valign=top><a name=d10921e655 class=n-a></a>&lt;3 years old</td></tr><tr><a name=d10921e659 class=n-a></a><td align=left colspan=2 rowspan=1 valign=top><a name=d10921e661 class=n-a></a>&lt;1.5 cm<sup>2</sup> residual disease after<br class=br>resection</td><td align=left colspan=2 rowspan=1 valign=top><a name=d10921e669 class=n-a></a>Subtotal resection, &gt;1.5 cm<sup>2</sup> residual tumor</td></tr><tr><a name=d10921e676 class=n-a></a><td align=left colspan=2 rowspan=1 valign=top><a name=d10921e678 class=n-a></a>M0 by craniospinal MRI and CSF</td><td align=left colspan=2 rowspan=1 valign=top><a name=d10921e681 class=n-a></a>M+, leptomeningeal seeding, and location outside of<br class=br>the posterior fossa</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d10921e691 class=n-a></a><p id=d10921e693> CSF, cerebrospinal fluid; MRI, magnetic resonance imaging.</p></div></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10921e702>Potentially new treatments and approaches</h2><p class="" id=d10921e705>With the advent of genomics, it has become increasingly clear that medulloblastoma is not a discrete entity, as shown by the recent WHO classification<sup><a href="#ref-8">8</a></sup>. Currently, there is a planned clinical study looking at the feasibility of surgery and chemotherapy in children with Wnt-positive medulloblastoma (NCT02212574). A Pediatric Brain Tumor Consortium study evaluated the use of GDC-0449 (vismodegib, Genentech Corporation, USA), which blocks a key protein (Smoothened, or SMO) in the SHH signaling pathway in medulloblastoma, and, as anticipated, patients with the SHH subtype who had the <i>SMO/PTCH</i> mutation responded to this drug<sup><a href="#ref-12">12</a></sup>. However, even in this group who responded to the vismodegib, it was transient with resistance developing quickly. Vismodegib has had some success in the recurrent SHH subgroup setting<sup><a href="#ref-12">12</a>,<a href="#ref-13">13</a></sup>. A proposed consensus for the design of next-generation clinical trials was discussed by Ramaswamy <i>et al.</i><sup><a href="#ref-14">14</a></sup> and is summarized in <a href="#T3">Table 3</a>.</p><div class="table-wrap panel clearfix"><a name=T3 class=n-a></a><div class=caption><h3>Table 3. Adapted table of a proposed consensus for designing the next generation of clinical trials in medulloblastoma (Ramaswamy <i>et al.</i><sup><a href="#ref-14">14</a></sup>).</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d10921e753 class=n-a></a><tbody><a name=d10921e755 class=n-a></a><tr><a name=d10921e757 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e759 class=n-a></a> <b>Medulloblastoma patient subgroups → genome-wide</b><br class=br><b>methylation array → molecularly informed clinical trial or</b><br class=br><b>other validated methods</b> </td></tr><tr><a name=d10921e772 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e774 class=n-a></a> <b>Tissue collection from all patients → snap-frozen and</b><br class=br><b>paraffin-embedded tumor tissue, blood, and CSF</b> </td></tr><tr><a name=d10921e784 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e786 class=n-a></a> <b>All patients require tumor board planning for a clinical trial</b><br class=br><b>registry: neuroimaging, neuropathology, and radiotherapy</b> </td></tr><tr><a name=d10921e796 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e798 class=n-a></a> <b>Treatment-related side effects in all patients in the short and</b><br class=br><b>long term: quality-of-life measures and neuropsychological</b><br class=br><b>outcomes</b> </td></tr><tr><a name=d10921e811 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e813 class=n-a></a> <b>Recurrent disease: tumors should be re-biopsied if the</b><br class=br><b>diagnosis was unclear, or 2 years after the initial diagnosis,</b><br class=br><b>or before using targeted therapy for 2 years</b> </td></tr><tr><a name=d10921e827 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d10921e829 class=n-a></a> <b>Extent of resection: neurosurgeons should aim for maximal</b><br class=br><b>safe removal</b> </td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d10921e843 class=n-a></a><p id=d10921e845> CSF, cerebrospinal fluid.</p></div></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10921e854>WNT subgroup of medulloblastoma</h2><p class="" id=d10921e857>WNT medulloblastomas have evidence of WNT pathway (<a href="#f2">Figure 2A</a>) activation in their transcription profiles and almost uniformly have oncogenic mutations of <i>CTNNB1</i>, the proto-oncogene that encodes β-catenin. This subgroup comprises 10–15% of all medulloblastomas, found mostly in females aged 6–10. Their expression profiles map to multipotential progenitor cells of the lower rhombic lip<sup><a href="#ref-15">15</a></sup>. According to Phoenix <i>et al.</i><sup><a href="#ref-16">16</a></sup>, there is a “signaling paradox” identified in which mutant catenin beta 1 (CTNNB1) protein drives constitutive, oncogenic WNT signaling in medulloblastoma<sup><a href="#ref-17">17</a>,<a href="#ref-18">18</a></sup>; this in turn silences normal WNT signaling in surrounding endothelial cells by producing inhibitors such as those of the secreted Frizzled-related protein (sFRP) family and WNT inhibitor factor 1 (WIF-1) that are secreted <i>in situ</i> (<a href="#f2">Figure 2A</a>). <i>CTNNB1</i> mutations are found in approximately 90% of WNT medulloblastomas, and nuclear accumulation of β-catenin is a biomarker for WNT pathway activation. WNT medulloblastomas form a highly hemorrhagic vasculature that lacks a blood–brain barrier<sup><a href="#ref-16">16</a></sup>. This may explain why these tumors are highly susceptible to chemotherapy, especially those that do not typically cross the blood–brain barrier, e.g. vincristine<sup><a href="#ref-16">16</a></sup>. Monosomy 6 is also found in 80–85% of WNT medulloblastomas (incidentally, these do not harbor telomerase reverse transcriptase [TERT] mutations), DEAD-box helicase 3 (DDX3X) mutations are found in 50% of WNT tumors, TERT mutations are found in 31% of WNT tumors<sup><a href="#ref-19">19</a></sup>, and the most common chromatin remodeling mutation found in WNT tumors is SMARCA4. Note that tumor suppressor protein p53 (TP53) mutations present in 15% of WNT tumors have no prognostic impact, unlike SHH TP53-mutant tumors that are associated with poor prognosis<sup><a href="#ref-20">20</a></sup>.</p><p class="" id=d10921e910>Patients with WNT medulloblastomas tend to have the most favorable outcomes; hence, current treatment protocols for WNT subgroup tumors are designed to minimize radiation and standard chemotherapy (refer to NCT01878617) and seek new treatments that target oncogenic mechanisms. Northcott <i>et al.</i><sup><a href="#ref-21">21</a></sup> suggested the use of panobinostat (a non-selective histone deacetylase inhibitor) (Novartis, USA) since the disruption of chromatin remodeling is thought to play a pivotal role in WNT medulloblastoma<sup><a href="#ref-22">22</a>,<a href="#ref-23">23</a></sup>. Anastas and Moon<sup><a href="#ref-22">22</a></sup> also discuss a number of other potential inhibitors to the WNT pathway in their review.</p><div class="fig panel clearfix"><a name=f2 class=n-a></a><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/11709/c9e8b92d-323a-4a64-b662-3ddae7434989_figure2.gif"><img alt="c9e8b92d-323a-4a64-b662-3ddae7434989_figure2.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/11709/c9e8b92d-323a-4a64-b662-3ddae7434989_figure2.gif"></a><div class=caption><h3>Figure 2. WNT and SHH signaling pathways.</h3><p id=d10921e940>(<b>A</b>) The WNT signaling pathway is mediated by the receptor Frizzled (FZ) and single-pass low-density lipoprotein receptor-related protein 5 or 6 (LRP5/6). In the pathway’s “off” state (in the event of low, no, or WNT ligand function inhibited by WNT inhibitor factor 1 [WIF-1] or secreted frizzle-related protein [SFRP]), β-catenin (β-cat) is targeted for phosphorylation by glycogen synthase kinase 3 (GSK3) and casein kinase I alpha (CKIα), aided by proteins AXIN and adenomatous polyposis coli (APC). β-catenin is then ubiquitinated and targeted for proteolysis by the proteasome. In the pathway’s “on” state, WNT ligand is recognized by FZ and LRP5/6, and LRP5/6 is phosphorylated. The WNT-FZ-LRP5/6 trimeric complex triggers the recognition of Dishevelled (DSH) and AXIN. β-catenin is not phosphorylated, translocates to the nucleus, and functions as a transcriptional coactivator to activate TCF/LEF family transcription factors. Prominent drug targets that aim to regulate WNT-responsive gene expression<sup><a href="#ref-22">22</a></sup> include those that target (1) extracellular events, such as recognition of WNT by FZ and/or LRP5/6 (vantictumab and ipafricept), (2) cytoplasmic events, such as inhibition of DSH or stabilization of the AXIN/APC interaction (IWR-1; XAV939; 3289-8625; FJ9; NSC 668036; JW74), and (3) transcriptional activation, such as perturbing β-catenin function (PFK115-584; CGP049090; iCRT-3, -5, and -14; PRI-724). There are still other drugs that target events involved in WNT secretion to the extracellular space as well as other enzymes that regulate the pathway, but they are not shown in this schematic. Ub, ubiquitin. (<b>B</b>) The sonic hedgehog (SHH) pathway is mediated by the receptors Smoothened (SMO) and Patched (PTC). In the pathway’s “off” state (in the event of low or no SHH ligand), SMO transport from intracellular vesicles to the membrane and its activity at the membrane are inhibited, in part by PTC. Members of transcription factor family GLI are inhibited by suppressor of fused (SUFU). Protein kinase A (PKA) phosphorylates the GLI transcription factors, which undergo proteasomal cleavage to yield a functional repressor form (GLI<sup>R</sup>). GLI<sup>R</sup> translocates to the nucleus and inhibits target gene expression. In the pathway’s “on” state, SHH binds to and inhibits PTC and SUFU is inhibited. SMO levels at the membrane increase, leading to activation of GLI transcription factors, which translocate to the nucleus to activate SHH-responsive genes. Prominent drug targets that aim to regulate SHH-responsive gene expression<sup><a href="#ref-13">13</a></sup> include those that target (1) extracellular events, such as SMO function, including by inhibition of SHH (purmorphamine, cyclopamine, vismodegib<sup><a href="#ref-12">12</a></sup>; sonidegib or Odomzo®, jervine; saridegib, CUR 61414, BMS-833923, glasdegib, PF-5274857, TAK-441, Taladegib, and SANT-1) and its binding to PTC (5E1, a monoclonal antibody), and (2) transcription activation, such as regulating GLI transcriptional activation (GANT61 and arsenic trioxide).</p></div></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10921e976>SHH subgroup of medulloblastoma</h2><p class="" id=d10921e979>The SHH medulloblastoma group is a complex heterogeneous group of tumors, and the pathway is delineated in <a href="#f2">Figure 2B</a>. SHH medulloblastomas have an intact blood–brain barrier and are less responsive to chemotherapy compared to WNT medulloblastomas<sup><a href="#ref-16">16</a></sup>. Infants (0–4 years) are more likely to have <i>SUFU</i> mutations than other age groups, and 42% of the infant samples have <i>PTCH1</i> alterations, while children (4–17 years) have a higher incidence of <i>MYCN</i> and <i>GLI2</i> amplifications, and 36% have <i>PTCH1</i> alterations<sup><a href="#ref-24">24</a>,<a href="#ref-25">25</a></sup>. Adults (anyone over the age of 17) are more likely to have <i>SMO</i> mutations than other age groups, and 54% of the adult samples have <i>PTCH1</i> alterations<sup><a href="#ref-25">25</a></sup>. Since there is a higher prevalence of <i>PTCH1</i> and <i>SMO</i> mutations in adult SHH medulloblastomas, this predicts responsiveness to inhibitors of the receptor SMO. Some tumors that arise from <i>SMO</i> mutations are sensitive to SMO inhibitors, but for others the <i>SMO</i> mutation renders the tumor insensitive<sup><a href="#ref-24">24</a></sup>. <i>MYCN</i> and <i>GLI2</i> amplifications or mutations also have been shown to be insensitive to SMO inhibitors<sup><a href="#ref-12">12</a>,<a href="#ref-13">13</a></sup>. SHH-inhibiting drugs that act downstream of SMO are currently in development<sup><a href="#ref-24">24</a></sup>. TERT promoter mutations are present in 38% of SHH medulloblastomas and, interestingly, are present in 80% of adult SHH tumors<sup><a href="#ref-19">19</a></sup>. Gorlin syndrome (also known as nevoid basal-cell carcinoma syndrome), caused by inherited germline <i>PTCH1</i> mutations or <i>de novo</i> (60% cases), is an autosomal dominant developmental disorder, and 5% of these individuals develop medulloblastomas during infancy<sup><a href="#ref-26">26</a></sup>. The outcome tends to be favorable as long as the patient does not have a <i>PTEN</i> or <i>GNAS</i> alteration<sup><a href="#ref-26">26</a></sup>. SHH-activated, <i>TP53</i>-mutant is a recent genetically defined WHO classification<sup><a href="#ref-8">8</a></sup>. <i>TP53</i> mutations occur in 13% of SHH tumors, and many of these are germline mutations (Li-Fraumeni syndrome)<sup><a href="#ref-23">23</a>,<a href="#ref-24">24</a></sup>. The SHH medulloblastomas with <i>TP53</i> mutations have extremely poor outcomes, and patients with these tumors should be selected for more intensive therapies and parents of those with germline mutations be offered genetic counseling<sup><a href="#ref-14">14</a></sup>. Protocols in development include removing DNA alkylating chemotherapy and minimizing radiation therapy in <i>TP53</i>-mutant tumors and relying instead on antimetabolite, microtubule-disrupting, or other types of chemotherapy<sup><a href="#ref-25">25</a></sup>. The SJMB12 study (NCT01878617) is currently prospectively evaluating treatment of SHH medulloblastoma in molecularly and clinically defined low, average, and high-risk patients and post-chemotherapy maintenance treatment with GDC0449 in children &gt;12 years of age. Also, PI3K, mTOR, arsenic trioxide, and AKT inhibitors are potentially valuable in controlling specific targets in the SHH pathway and its interaction and links with the PI3K, mTOR, and AKT pathways<sup><a href="#ref-25">25</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10921e1122>Non-WNT/non-SHH: group 3 medulloblastoma</h2><p class="" id=d10921e1125>Patients with group 3 medulloblastoma have a poor prognosis, and more than 50% of cases are metastatic at the time of diagnosis<sup><a href="#ref-4">4</a></sup>. Interestingly, older children with group 3 medulloblastomas have a 50% survival in 5 years if they have risk-adapted therapy. These tumors are more common in males and infants. This subgroup is notable for <i>MYC</i> over-expression, with <i>MYC</i> amplification observed in 17% of cases<sup><a href="#ref-3">3</a></sup>. Isochromosome 17q is a predictor of poor outcome in group 3 medulloblastomas<sup><a href="#ref-27">27</a></sup>. A large proportion of these group 3 medulloblastomas overexpress GABRA5, which may have therapeutic implications<sup><a href="#ref-3">3</a>,<a href="#ref-28">28</a>–<a href="#ref-31">31</a></sup>. Mutations in a number of genes involving chromatin remodeling affect 28.5% of group 3 tumors<sup><a href="#ref-31">31</a></sup>. Copy number changes that target genes in the transforming growth factor beta (TGF-β) signaling pathway affect approximately 20% of group 3 tumors<sup><a href="#ref-31">31</a></sup>. In addition, <i>PTV1</i> alterations are present in 12% of tumors, often as a fusion with <i>MYC</i> that drives its expression<sup><a href="#ref-31">31</a></sup>. The Wechsler-Reya group has shown HDAC and PI3K inhibitor combinations are promising in models of group 3 medulloblastoma<sup><a href="#ref-30">30</a></sup>. The SJMB12 study (for all medulloblastoma subgroups, mentioned in the previous section) is also prospectively evaluating the use of pemetrexed, gemcitabine, vincristine, cisplatin, and cyclophosphamide in the high-risk medulloblastoma cases, and this study is currently open.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10921e1183>Non-WNT/non-SHH: group 4 medulloblastoma</h2><p class="" id=d10921e1186>Group 4 medulloblastoma is also known as the glutamatergic subgroup, and it is the commonest molecular subgroup. For specific characteristics of this subgroup, please refer to <a href="#T1">Table 1</a>. The average-risk patients in this subgroup have excellent survival with the current standard-of-care treatment options<sup><a href="#ref-11">11</a></sup>. It has a phototransduction and neuronal signature in its transcription profile, as initially described by Cho <i>et al.</i><sup><a href="#ref-3">3</a></sup>. However, more recently, the homeobox transcription factor Lmx1A has been identified as a master regulator transcription factor of group 4 medulloblastomas<sup><a href="#ref-32">32</a></sup>. Lmx1A is important in the normal development of cells in the upper rhombic lip and cerebellum, and it is also critical for the development of midbrain dopaminergic neurons<sup><a href="#ref-31">31</a>,<a href="#ref-32">32</a></sup>, which are thought to be where group 4 tumors originate. Interestingly, this subgroup of medulloblastoma is three times more common in males than in females<sup><a href="#ref-4">4</a></sup>. More recently, the presence of metastatic disease at diagnosis or chromosome 11 loss and chromosome 17 gain appear to dictate the prognosis in this subgroup of medulloblastoma patients<sup><a href="#ref-27">27</a></sup>. In addition, copy number changes in target genes that are important in the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κβ) signaling pathway are found in this subgroup<sup><a href="#ref-29">29</a>,<a href="#ref-31">31</a></sup>. The most common chromosomal aberration found in group 4 tumors is isochromosome 17q; it is also found to a lesser degree in group 3 tumors<sup><a href="#ref-4">4</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10921e1236>Recurrent medulloblastomas</h2><p class="" id=d10921e1239>Despite the subgroup designation of medulloblastomas, at recurrence (tumor relapse with or without leptomeningeal dissemination), there is substantial divergence of the dominant clone<sup><a href="#ref-33">33</a></sup>. Interestingly, however, subgroup classification is maintained at recurrence or metastasis<sup><a href="#ref-33">33</a></sup>. Most medulloblastomas that recur post-cytotoxic therapies are fatal, and the patterns of relapse tend to be subgroup specific. The concept of intratumor heterogeneity was initially described by Gerlinger <i>et al.</i><sup><a href="#ref-34">34</a></sup> for renal cell cancer, and more recently for medulloblastoma<sup><a href="#ref-35">35</a></sup>. In addition, the microenvironment of the tumor will have implications for drug design, including immunotherapies<sup><a href="#ref-36">36</a></sup>. This might be why, despite the design of targeted clinical trials, there is failure of these targeted agents<sup><a href="#ref-37">37</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10921e1272>Secondary tumors following treatment of medulloblastomas</h2><p class="" id=d10921e1275>There is the added caveat of medulloblastoma patients who survive radiation and chemotherapy who then go on to develop other tumors such as meningiomas and gliomas<sup><a href="#ref-37">37</a></sup>, etc. Packer <i>et al.</i><sup><a href="#ref-37">37</a></sup> in the Children’s Oncology Group A9961 trial described a cohort of 379 patients (aged 3 to 21), and 15 of these patients went on to develop secondary tumors 5.8 years after their initial diagnosis of medulloblastoma. Thus, recurrence and secondary cancers post-standard treatment of medulloblastoma patients makes monitoring of this pediatric population well into adulthood a necessity.</p><p class="" id=d10921e1288>Many groups are looking at targeted next-generation sequencing approaches in neuro-oncology in the initial diagnosis and recurrent setting to improve treatment options<sup><a href="#ref-38">38</a></sup>, since there is a lack of validated targets for non-SHH/WNT medulloblastoma that sequencing may help unravel. In addition, many cancers, including medulloblastomas, have DDX3X mutations, as briefly discussed in the WNT section, and recent work has shown that mutations in this gene result in global reduced translation<sup><a href="#ref-39">39</a></sup>. This may confer certain survival advantages, perhaps in certain microenvironments, which may aid in designing alternative therapeutic options<sup><a href="#ref-36">36</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10921e1306>Future directions</h2><p class="" id=d10921e1309>Despite dissecting medulloblastomas in the “genomic sense”, it is clear that therapy cannot be dictated by the subgroups alone. There are other key players, and epigenetics has a big role to play<sup><a href="#ref-40">40</a></sup>. Indeed, it is becoming increasingly clear that global changes in the epigenetic architecture are signatures of cancer and tumorigenesis. It was described in 2014 by Diede <i>et al.</i><sup><a href="#ref-41">41</a></sup> that DNA methylation probably prevents normal differentiation in pediatric cancers. It is known that focal regions of low methylation linked to transcription-factor-binding sites shed light on differential transcriptional networks between subgroups; however, increased methylation correlates with gene expression<sup><a href="#ref-41">41</a>,<a href="#ref-42">42</a></sup>.</p><p class="" id=d10921e1329>Although in its infancy in medulloblastoma, proteomics is another strategy being utilized to analyze the tumor microenvironment, since other metabolites, such as small peptides and lipids, can be crucial in regulating tumor development<sup><a href="#ref-43">43</a></sup>. Summarizing the future of medulloblastoma treatment, numerous strategies for designing and tailoring treatment for medulloblastoma will evolve to harness the different technologies, such as genomics, methylomics, and proteomics. Even though personalized medicine is not de rigueur in medulloblastoma management, it is something that is on the horizon.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d10921e1340>Abbreviations</h2><p class="" id=d10921e1343>CTNNB1, catenin beta 1; DDX3X, DEAD-box helicase 3; SHH, sonic hedgehog signaling pathway; TERT, telomerase reverse transcriptase; TP53, tumor suppressor protein p53; WNT, Wnt signaling pathway.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d10921e1 class=n-a></a><h2 class=main-title id=d11078>Competing interests</h2><p class=metadata-entry><a name=d10921e111 class=n-a></a><p id=d10921e113> The authors declare that they have no competing interests.</p></p></div><div class=back-section><a name=d10921e1 class=n-a></a><h2 class=main-title id=d11080>Grant information</h2><p>Soma Sengupta is supported by the National Institute of Neurological Disorders and Stroke grant (K08 NS083626), and the Winship Cancer Institute Institutional Research grant (IRG-14-188-01) from the American Cancer Society.</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript</i>.</p></div><div class=back-section><a name=d10921e1350 class=n-a></a><h2 class=main-title id=d10921e1352>Acknowledgements</h2><p class="" id=d10921e1355>We would like to thank Dr Tobey MacDonald for a critical review of the manuscript and the reviewers for their constructive feedback. We would also like to thank Drs Richard Robertson (Radiology, Boston Children’s Hospital) and Chad Holder (Radiology and Imaging Sciences, Emory University Hospital) for producing publication-quality MRI images for this review.</p></div><div class=back-section><a name=d10921e1359 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d11242>References</h2><div class="section ref-list"><a name=d10921e1359 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d10921e1366 class=n-a></a>Ostrom QT, Gittleman H, Liao P, <i> et al.</i>: CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007–2011. <i>Neuro Oncol.</i> 2014; <b>16</b>(Suppl 4): iv1–63. <a target=xrefwindow id=d10921e1377 href="http://www.ncbi.nlm.nih.gov/pubmed/25304271">PubMed Abstract </a> | <a target=xrefwindow id=d10921e1380 href="http://dx.doi.org/10.1093/neuonc/nou223">Publisher Full Text </a> | <a target=xrefwindow id=d10921e1384 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4193675">Free Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d10921e1393 class=n-a></a>Gajjar A, Packer RJ, Foreman NK, <i> et al.</i>: Children's Oncology Group's 2013 blueprint for research: central nervous system tumors. <i>Pediatr Blood Cancer.</i> 2013; <b>60</b>(6): 1022–6. <a target=xrefwindow id=d10921e1404 href="http://www.ncbi.nlm.nih.gov/pubmed/23255213">PubMed Abstract </a> | <a target=xrefwindow id=d10921e1407 href="http://dx.doi.org/10.1002/pbc.24427">Publisher Full Text </a> | <a target=xrefwindow id=d10921e1411 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4184243">Free Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d10921e1420 class=n-a></a>Cho YJ, Tsherniak A, Tamayo P, <i> et al.</i>: Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. <i>J Clin Oncol.</i> 2011; <b>29</b>(11): 1424–30. <a target=xrefwindow id=d10921e1431 href="http://www.ncbi.nlm.nih.gov/pubmed/21098324">PubMed Abstract </a> | <a target=xrefwindow id=d10921e1434 href="http://dx.doi.org/10.1200/JCO.2010.28.5148">Publisher Full Text </a> | <a target=xrefwindow id=d10921e1438 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3082983">Free Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717989056"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10921e1447 class=n-a></a>Kool M, Korshunov A, Remke M, <i> et al.</i>: Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. <i>Acta Neuropathol.</i> 2012; <b>123</b>(4): 473–84. <a target=xrefwindow id=d10921e1458 href="http://www.ncbi.nlm.nih.gov/pubmed/22358457">PubMed Abstract </a> | <a target=xrefwindow id=d10921e1461 href="http://dx.doi.org/10.1007/s00401-012-0958-8">Publisher Full Text </a> | <a target=xrefwindow id=d10921e1465 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3306778">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717989056">F1000 Recommendation</a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718390950"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10921e1478 class=n-a></a>Taylor MD, Northcott PA, Korshunov A, <i> et al.</i>: Molecular subgroups of medulloblastoma: the current consensus. <i>Acta Neuropathol.</i> 2012; <b>123</b>(4): 465–72. <a target=xrefwindow id=d10921e1489 href="http://www.ncbi.nlm.nih.gov/pubmed/22134537">PubMed Abstract </a> | <a target=xrefwindow id=d10921e1492 href="http://dx.doi.org/10.1007/s00401-011-0922-z">Publisher Full Text </a> | <a target=xrefwindow id=d10921e1496 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3306779">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718390950">F1000 Recommendation</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717962611"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10921e1510 class=n-a></a>Jones DT, Jäger N, Kool M, <i> et al.</i>: Dissecting the genomic complexity underlying medulloblastoma. <i>Nature.</i> 2012; <b>488</b>(7409): 100–5. <a target=xrefwindow id=d10921e1521 href="http://www.ncbi.nlm.nih.gov/pubmed/22832583">PubMed Abstract </a> | <a target=xrefwindow id=d10921e1524 href="http://dx.doi.org/10.1038/nature11284">Publisher Full Text </a> | <a target=xrefwindow id=d10921e1528 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3662966">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717962611">F1000 Recommendation</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d10921e1541 class=n-a></a>Bailey P, Cushing H: Medulloblastoma cerebelli: a common type of midcerebellar glioma of childhood. <i>Arch Neurol Psychiatry.</i> 1925;<b>14</b>(2): 192–223. <a target=xrefwindow id=d10921e1549 href="http://dx.doi.org/10.1001/archneurpsyc.1925.02200140055002">Publisher Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d10921e1558 class=n-a></a>Louis DN, Ohgaki H, Wiestler OD, <i> et al.</i>: WHO classification of tumors of the central nervous system. Revised 4th edition. 2016; 184–200. <a target=xrefwindow id=d10921e1563 href="http://publications.iarc.fr/Book-And-Report-Series/Who-Iarc-Classification-Of-Tumours/Who-Classification-Of-Tumours-Of-The-Central-Nervous-System-2016">Reference Source</a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d10921e1572 class=n-a></a>Packer RJ, Vezina G: Management of and prognosis with medulloblastoma: therapy at a crossroads. <i>Arch Neurol.</i> 2008; <b>65</b>(11): 1419–24. <a target=xrefwindow id=d10921e1580 href="http://www.ncbi.nlm.nih.gov/pubmed/19001159">PubMed Abstract </a> | <a target=xrefwindow id=d10921e1583 href="http://dx.doi.org/10.1001/archneur.65.11.1419">Publisher Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727144199"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10921e1592 class=n-a></a>Tamburrini G, Frassanito P, Chieffo D, <i> et al.</i>: Cerebellar mutism. <i>Childs Nerv Syst.</i> 2015; <b>31</b>(10): 1841–51. <a target=xrefwindow id=d10921e1603 href="http://www.ncbi.nlm.nih.gov/pubmed/26351234">PubMed Abstract </a> | <a target=xrefwindow id=d10921e1606 href="http://dx.doi.org/10.1007/s00381-015-2803-6">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727144199">F1000 Recommendation</a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d10921e1619 class=n-a></a>MacDonald TJ, Packer RJ: Pediatric Medulloblastoma. <i>Medscape Drugs &amp; Diseases.</i> 2014. <a target=xrefwindow id=d10921e1624 href="http://reference.medscape.com/article/987886-overview">Reference Source</a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725633683"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10921e1634 class=n-a></a>Robinson GW, Orr BA, Wu G, <i> et al.</i>: Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032. <i>J Clin Oncol.</i> 2015; <b>33</b>(24): 2646–54. <a target=xrefwindow id=d10921e1645 href="http://www.ncbi.nlm.nih.gov/pubmed/26169613">PubMed Abstract </a> | <a target=xrefwindow id=d10921e1648 href="http://dx.doi.org/10.1200/JCO.2014.60.1591">Publisher Full Text </a> | <a target=xrefwindow id=d10921e1652 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4534527">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725633683">F1000 Recommendation</a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725676465"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10921e1665 class=n-a></a>Samkari A, White J, Packer R: SHH inhibitors for the treatment of medulloblastoma. <i>Expert Rev Neurother.</i> 2015; <b>15</b>(7): 763–70. <a target=xrefwindow id=d10921e1673 href="http://www.ncbi.nlm.nih.gov/pubmed/26027634">PubMed Abstract </a> | <a target=xrefwindow id=d10921e1676 href="http://dx.doi.org/10.1586/14737175.2015.1052796">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725676465">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d10921e1689 class=n-a></a>Ramaswamy V, Remke M, Bouffet E, <i> et al.</i>: Risk stratification of childhood medulloblastoma in the molecular era: the current consensus. <i>Acta Neuropathol.</i> 2016; <b>131</b>(6): 821–31. <a target=xrefwindow id=d10921e1700 href="http://www.ncbi.nlm.nih.gov/pubmed/27040285">PubMed Abstract </a> | <a target=xrefwindow id=d10921e1703 href="http://dx.doi.org/10.1007/s00401-016-1569-6">Publisher Full Text </a> | <a target=xrefwindow id=d10921e1707 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4867119">Free Full Text </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717747856"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10921e1716 class=n-a></a>Robinson G, Parker M, Kranenburg TA, <i> et al.</i>: Novel mutations target distinct subgroups of medulloblastoma. <i>Nature.</i> 2012; <b>488</b>(7409): 43–8. <a target=xrefwindow id=d10921e1727 href="http://www.ncbi.nlm.nih.gov/pubmed/22722829">PubMed Abstract </a> | <a target=xrefwindow id=d10921e1730 href="http://dx.doi.org/10.1038/nature11213">Publisher Full Text </a> | <a target=xrefwindow id=d10921e1734 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3412905">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717747856">F1000 Recommendation</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726268055"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10921e1747 class=n-a></a>Phoenix TN, Patmore DM, Boop S, <i> et al.</i>: Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype. <i>Cancer Cell.</i> 2016; <b>29</b>(4): 508–22. <a target=xrefwindow id=d10921e1758 href="http://www.ncbi.nlm.nih.gov/pubmed/27050100">PubMed Abstract </a> | <a target=xrefwindow id=d10921e1761 href="http://dx.doi.org/10.1016/j.ccell.2016.03.002">Publisher Full Text </a> | <a target=xrefwindow id=d10921e1765 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4829447">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726268055">F1000 Recommendation</a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a name=d10921e1778 class=n-a></a>Gibson P, Tong Y, Robinson G, <i> et al.</i>: Subtypes of medulloblastoma have distinct developmental origins. <i>Nature.</i> 2010; <b>468</b>(7327): 1095–9. <a target=xrefwindow id=d10921e1789 href="http://www.ncbi.nlm.nih.gov/pubmed/21150899">PubMed Abstract </a> | <a target=xrefwindow id=d10921e1792 href="http://dx.doi.org/10.1038/nature09587">Publisher Full Text </a> | <a target=xrefwindow id=d10921e1796 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3059767">Free Full Text </a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a name=d10921e1806 class=n-a></a>Clevers H, Nusse R: Wnt/β-catenin signaling and disease. <i>Cell.</i> 2012; <b>149</b>(6): 1192–205. <a target=xrefwindow id=d10921e1814 href="http://www.ncbi.nlm.nih.gov/pubmed/22682243">PubMed Abstract </a> | <a target=xrefwindow id=d10921e1817 href="http://dx.doi.org/10.1016/j.cell.2012.05.012">Publisher Full Text </a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a name=d10921e1826 class=n-a></a>Remke M, Ramaswamy V, Peacock J, <i> et al.</i>: <i>TERT</i> promoter mutations are highly recurrent in SHH subgroup medulloblastoma. <i>Acta Neuropathol.</i> 2013; <b>126</b>(6): 917–29. <a target=xrefwindow id=d10921e1840 href="http://www.ncbi.nlm.nih.gov/pubmed/24174164">PubMed Abstract </a> | <a target=xrefwindow id=d10921e1844 href="http://dx.doi.org/10.1007/s00401-013-1198-2">Publisher Full Text </a> | <a target=xrefwindow id=d10921e1847 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3830749">Free Full Text </a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726820734"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10921e1856 class=n-a></a>Chiang JC, Ellison DW: Molecular pathology of paediatric central nervous system tumours. <i>J Pathol.</i> 2017; <b>241</b>(2): 159–72. <a target=xrefwindow id=d10921e1864 href="http://www.ncbi.nlm.nih.gov/pubmed/27701736">PubMed Abstract </a> | <a target=xrefwindow id=d10921e1867 href="http://dx.doi.org/10.1002/path.4813">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726820734">F1000 Recommendation</a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d10921e1880 class=n-a></a>Northcott PA, Jones DT, Kool M, <i> et al.</i>: Medulloblastomics: the end of the beginning. <i>Nat Rev Cancer.</i> 2012; <b>12</b>(12): 818–34. <a target=xrefwindow id=d10921e1891 href="http://www.ncbi.nlm.nih.gov/pubmed/23175120">PubMed Abstract </a> | <a target=xrefwindow id=d10921e1894 href="http://dx.doi.org/10.1038/nrc3410">Publisher Full Text </a> | <a target=xrefwindow id=d10921e1898 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3889646">Free Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a name=d10921e1907 class=n-a></a>Anastas JN, Moon RT: WNT signalling pathways as therapeutic targets in cancer. <i>Nat Rev Cancer.</i> 2013; <b>13</b>(1): 11–26. <a target=xrefwindow id=d10921e1915 href="http://www.ncbi.nlm.nih.gov/pubmed/23258168">PubMed Abstract </a> | <a target=xrefwindow id=d10921e1918 href="http://dx.doi.org/10.1038/nrc3419">Publisher Full Text </a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d10921e1927 class=n-a></a>Kahn M: Can we safely target the WNT pathway? <i>Nat Rev Drug Discov.</i> 2014; <b>13</b>(7): 513–32. <a target=xrefwindow id=d10921e1935 href="http://www.ncbi.nlm.nih.gov/pubmed/24981364">PubMed Abstract </a> | <a target=xrefwindow id=d10921e1938 href="http://dx.doi.org/10.1038/nrd4233">Publisher Full Text </a> | <a target=xrefwindow id=d10921e1941 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4426976">Free Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718097744"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10921e1951 class=n-a></a>Zhukova N, Ramaswamy V, Remke M, <i> et al.</i>: Subgroup-specific prognostic implications of <i>TP53</i> mutation in medulloblastoma. <i>J Clin Oncol.</i> 2013; <b>31</b>(23): 2927–35. <a target=xrefwindow id=d10921e1965 href="http://www.ncbi.nlm.nih.gov/pubmed/23835706">PubMed Abstract </a> | <a target=xrefwindow id=d10921e1969 href="http://dx.doi.org/10.1200/JCO.2012.48.5052">Publisher Full Text </a> | <a target=xrefwindow id=d10921e1972 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4878050">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718097744">F1000 Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d10921e1985 class=n-a></a>Kool M, Jones DT, Jäger N, <i> et al.</i>: Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. <i>Cancer Cell.</i> 2014; <b>25</b>(3): 393–405. <a target=xrefwindow id=d10921e1996 href="http://www.ncbi.nlm.nih.gov/pubmed/24651015">PubMed Abstract </a> | <a target=xrefwindow id=d10921e1999 href="http://dx.doi.org/10.1016/j.ccr.2014.02.004">Publisher Full Text </a> | <a target=xrefwindow id=d10921e2003 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4493053">Free Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725465424"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10921e2012 class=n-a></a>Gururangan S, Robinson G, Ellison DW, <i> et al.</i>: Gorlin syndrome and desmoplastic medulloblastoma: Report of 3 cases with unfavorable clinical course and novel mutations. <i>Pediatr Blood Cancer.</i> 2015; <b>62</b>(10): 1855–8. <a target=xrefwindow id=d10921e2023 href="http://www.ncbi.nlm.nih.gov/pubmed/25940061">PubMed Abstract </a> | <a target=xrefwindow id=d10921e2026 href="http://dx.doi.org/10.1002/pbc.25560">Publisher Full Text </a> | <a target=xrefwindow id=d10921e2030 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4765346">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725465424">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d10921e2043 class=n-a></a>Shih DJ, Northcott PA, Remke M, <i> et al.</i>: Cytogenetic prognostication within medulloblastoma subgroups. <i>J Clin Oncol.</i> 2014; <b>32</b>(9): 886–96. <a target=xrefwindow id=d10921e2054 href="http://www.ncbi.nlm.nih.gov/pubmed/24493713">PubMed Abstract </a> | <a target=xrefwindow id=d10921e2057 href="http://dx.doi.org/10.1200/JCO.2013.50.9539">Publisher Full Text </a> | <a target=xrefwindow id=d10921e2061 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3948094">Free Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d10921e2070 class=n-a></a>Sengupta S, Weeraratne SD, Cho Y, <i> et al.</i>: Could α5-GABA-A receptor activation be used as a target for managing medulloblastomas? <i>CNS Oncol.</i> 2014; <b>3</b>(4): 245–7. <a target=xrefwindow id=d10921e2081 href="http://www.ncbi.nlm.nih.gov/pubmed/25286034">PubMed Abstract </a> | <a target=xrefwindow id=d10921e2084 href="http://dx.doi.org/10.2217/cns.14.27">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717962613"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10921e2093 class=n-a></a>Pugh TJ, Weeraratne SD, Archer TC, <i> et al.</i>: Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. <i>Nature.</i> 2012; <b>488</b>(7409): 106–10. <a target=xrefwindow id=d10921e2104 href="http://www.ncbi.nlm.nih.gov/pubmed/22820256">PubMed Abstract </a> | <a target=xrefwindow id=d10921e2107 href="http://dx.doi.org/10.1038/nature11329">Publisher Full Text </a> | <a target=xrefwindow id=d10921e2111 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3413789">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717962613">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726218956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10921e2125 class=n-a></a>Pei Y, Liu KW, Wang J, <i> et al.</i>: HDAC and PI3K Antagonists Cooperate to Inhibit Growth of <i>MYC</i>-Driven Medulloblastoma. <i>Cancer Cell.</i> 2016; <b>29</b>(3): 311–23. <a target=xrefwindow id=d10921e2139 href="http://www.ncbi.nlm.nih.gov/pubmed/26977882">PubMed Abstract </a> | <a target=xrefwindow id=d10921e2143 href="http://dx.doi.org/10.1016/j.ccell.2016.02.011">Publisher Full Text </a> | <a target=xrefwindow id=d10921e2146 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4794752">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726218956">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717962612"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10921e2159 class=n-a></a>Northcott PA, Shih DJ, Peacock J, <i> et al.</i>: Subgroup-specific structural variation across 1,000 medulloblastoma genomes. <i>Nature.</i> 2012; <b>488</b>(7409): 49–56. <a target=xrefwindow id=d10921e2170 href="http://www.ncbi.nlm.nih.gov/pubmed/22832581">PubMed Abstract </a> | <a target=xrefwindow id=d10921e2173 href="http://dx.doi.org/10.1038/nature11327">Publisher Full Text </a> | <a target=xrefwindow id=d10921e2177 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3683624">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717962612">F1000 Recommendation</a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726105854"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10921e2190 class=n-a></a>Lin CY, Erkek S, Tong Y, <i> et al.</i>: Active medulloblastoma enhancers reveal subgroup-specific cellular origins. <i>Nature.</i> 2016; <b>530</b>(7588): 57–62. <a target=xrefwindow id=d10921e2201 href="http://www.ncbi.nlm.nih.gov/pubmed/26814967">PubMed Abstract </a> | <a target=xrefwindow id=d10921e2204 href="http://dx.doi.org/10.1038/nature16546">Publisher Full Text </a> | <a target=xrefwindow id=d10921e2208 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5168934">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726105854">F1000 Recommendation</a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718149036"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10921e2221 class=n-a></a>Ramaswamy V, Remke M, Bouffet E, <i> et al.</i>: Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis. <i>Lancet Oncol.</i> 2013; <b>14</b>(12): 1200–7. <a target=xrefwindow id=d10921e2232 href="http://www.ncbi.nlm.nih.gov/pubmed/24140199">PubMed Abstract </a> | <a target=xrefwindow id=d10921e2235 href="http://dx.doi.org/10.1016/S1470-2045(13)70449-2">Publisher Full Text </a> | <a target=xrefwindow id=d10921e2239 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3953419">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718149036">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/14001976"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10921e2252 class=n-a></a>Gerlinger M, Rowan AJ, Horswell S, <i> et al.</i>: Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. <i>N Engl J Med.</i> 2012; <b>366</b>(10): 883–92. <a target=xrefwindow id=d10921e2263 href="http://www.ncbi.nlm.nih.gov/pubmed/22397650">PubMed Abstract </a> | <a target=xrefwindow id=d10921e2266 href="http://dx.doi.org/10.1056/NEJMoa1113205">Publisher Full Text </a> | <a target=xrefwindow id=d10921e2270 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4878653">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/14001976">F1000 Recommendation</a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726072250"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10921e2283 class=n-a></a>Morrissy AS, Garzia L, Shih DJ, <i> et al.</i>: Divergent clonal selection dominates medulloblastoma at recurrence. <i>Nature.</i> 2016; <b>529</b>(7586): 351–7. <a target=xrefwindow id=d10921e2294 href="http://www.ncbi.nlm.nih.gov/pubmed/26760213">PubMed Abstract </a> | <a target=xrefwindow id=d10921e2297 href="http://dx.doi.org/10.1038/nature16478">Publisher Full Text </a> | <a target=xrefwindow id=d10921e2301 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4936195">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726072250">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d10921e2315 class=n-a></a>Pham CD, Mitchell DA: Know your neighbors: Different tumor microenvironments have implications in immunotherapeutic targeting strategies across MB subgroups. <i>Oncoimmunology.</i> 2016; <b>5</b>(11): e1144002. <a target=xrefwindow id=d10921e2323 href="http://www.ncbi.nlm.nih.gov/pubmed/27999733">PubMed Abstract </a> | <a target=xrefwindow id=d10921e2326 href="http://dx.doi.org/10.1080/2162402X.2016.1144002">Publisher Full Text </a> | <a target=xrefwindow id=d10921e2329 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5139647">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d10921e2338 class=n-a></a>Packer RJ, Zhou T, Holmes E, <i> et al.</i>: Survival and secondary tumors in children with medulloblastoma receiving radiotherapy and adjuvant chemotherapy: results of Children's Oncology Group trial A9961. <i>Neuro Oncol.</i> 2013; <b>15</b>(1): 97–103. <a target=xrefwindow id=d10921e2349 href="http://www.ncbi.nlm.nih.gov/pubmed/23099653">PubMed Abstract </a> | <a target=xrefwindow id=d10921e2352 href="http://dx.doi.org/10.1093/neuonc/nos267">Publisher Full Text </a> | <a target=xrefwindow id=d10921e2356 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3534419">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727110829"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10921e2365 class=n-a></a>Kline CN, Joseph NM, Grenert JP, <i> et al.</i>: Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. <i>Neuro Oncol.</i> 2016; pii: now254. <a target=xrefwindow id=d10921e2373 href="http://www.ncbi.nlm.nih.gov/pubmed/27978508">PubMed Abstract </a> | <a target=xrefwindow id=d10921e2376 href="http://dx.doi.org/10.1093/neuonc/now254">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727110829">F1000 Recommendation</a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726360739"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10921e2389 class=n-a></a>Valentin-Vega YA, Wang YD, Parker M, <i> et al.</i>: Cancer-associated DDX3X mutations drive stress granule assembly and impair global translation. <i>Sci Rep.</i> 2016; <b>6</b>: 25996. <a target=xrefwindow id=d10921e2400 href="http://www.ncbi.nlm.nih.gov/pubmed/27180681">PubMed Abstract </a> | <a target=xrefwindow id=d10921e2403 href="http://dx.doi.org/10.1038/srep25996">Publisher Full Text </a> | <a target=xrefwindow id=d10921e2407 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4867597">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726360739">F1000 Recommendation</a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d10921e2420 class=n-a></a>Batora NV, Sturm D, Jones DT, <i> et al.</i>: Transitioning from genotypes to epigenotypes: why the time has come for medulloblastoma epigenomics. <i>Neuroscience.</i> 2014; <b>264</b>: 171–85. <a target=xrefwindow id=d10921e2431 href="http://www.ncbi.nlm.nih.gov/pubmed/23876321">PubMed Abstract </a> | <a target=xrefwindow id=d10921e2434 href="http://dx.doi.org/10.1016/j.neuroscience.2013.07.030">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a name=d10921e2443 class=n-a></a>Diede SJ, Guenthoer J, Geng LN, <i> et al.</i>: DNA methylation of developmental genes in pediatric medulloblastomas identified by denaturation analysis of methylation differences. <i>Proc Natl Acad Sci U S A.</i> 2010; <b>107</b>(1): 234–9. <a target=xrefwindow id=d10921e2454 href="http://www.ncbi.nlm.nih.gov/pubmed/19966297">PubMed Abstract </a> | <a target=xrefwindow id=d10921e2457 href="http://dx.doi.org/10.1073/pnas.0907606106">Publisher Full Text </a> | <a target=xrefwindow id=d10921e2461 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2806770">Free Full Text </a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718408821"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10921e2471 class=n-a></a>Hovestadt V, Jones DT, Picelli S, <i> et al.</i>: Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing. <i>Nature.</i> 2014; <b>510</b>(7506): 537–41. <a target=xrefwindow id=d10921e2482 href="http://www.ncbi.nlm.nih.gov/pubmed/24847876">PubMed Abstract </a> | <a target=xrefwindow id=d10921e2485 href="http://dx.doi.org/10.1038/nature13268">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718408821">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725596185"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d10921e2498 class=n-a></a>Staal JA, Lau LS, Zhang H, <i> et al.</i>: Proteomic profiling of high risk medulloblastoma reveals functional biology. <i>Oncotarget.</i> 2015; <b>6</b>(16): 14584–95. <a target=xrefwindow id=d10921e2509 href="http://www.ncbi.nlm.nih.gov/pubmed/25970789">PubMed Abstract </a> | <a target=xrefwindow id=d10921e2512 href="http://dx.doi.org/10.18632/oncotarget.3927">Publisher Full Text </a> | <a target=xrefwindow id=d10921e2516 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4546489">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725596185">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 13 Apr 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-490&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-490&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Winship Cancer Institute, Emory University Hospital, Atlanta, GA, USA<br/> <sup>2</sup> F.M. Kirby Neurobiology Center, Boston Children&rsquo;s Hospital, Boston, MA, USA<br/> <p> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-490/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 13 Apr 2017, 6:490 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.10859.1">https://doi.org/10.12688/f1000research.10859.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 Sengupta S <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Data associated with the article are available under the terms of the <a href="http://creativecommons.org/publicdomain/zero/1.0/" target=_blank data-test-id=box-data-licence-link>Creative Commons Zero "No rights reserved" data waiver</a> (CC0 1.0 Public domain dedication). </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=11709 data-id=10859 data-downloads="" data-views="" data-scholar="10.12688/f1000research.10859.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-490/v1/pdf?article_uuid=86e1cc06-42f1-4e9d-bafd-1e9a2958d65d" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.10859.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Sengupta S, Pomeranz Krummel D and Pomeroy S. The evolution of medulloblastoma therapy to personalized medicine [version 1; peer review: 3 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):490 (<a href="https://doi.org/10.12688/f1000research.10859.1" target=_blank>https://doi.org/10.12688/f1000research.10859.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=10859 id=mobile-track-article-signin-10859 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/10859?target=/articles/6-490"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=11709 /> <input name=articleId type=hidden value=10859 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>James T Rutka</strong>, Division of Neurosurgery, The Hospital for Sick Children, Canada </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Sridharan Gururangan</strong>, Preston A. Wells Center for Brain Tumor Therapy, Department of Neurosurgery, McKnight Brain Institute, University of Florida, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Charles Eberhart</strong>, Johns Hopkins Hospital, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 13 Apr 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-490&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-490&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=21824-21580></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=21825-21578></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=21823-21579></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=3><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> <th class="c-report-timeline__headings-version p-article__color--dark">3</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-490/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>13 Apr 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>James T Rutka</strong>, Division of Neurosurgery, The Hospital for Sick Children, Canada </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Sridharan Gururangan</strong>, Preston A. Wells Center for Brain Tumor Therapy, Department of Neurosurgery, McKnight Brain Institute, University of Florida, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Charles Eberhart</strong>, Johns Hopkins Hospital, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-490&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-490/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "The evolution of medulloblastoma therapy...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-490/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-490/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-490/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Sengupta S et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-490/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-490",
            templates : {
                twitter : "The evolution of medulloblastoma therapy to personalized medicine. Sengupta S et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-490/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: The evolution of medulloblastoma therapy to personalized medicine", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: The evolution of medulloblastoma therapy to personalized medicine", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/10859/11709")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "11709");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "21578": 0,
                           "21579": 0,
                           "21580": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "4c537c02-c462-4bc7-8d49-fb911d814ede";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-490.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-490.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-490.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-490.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-490.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>